| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.1M | +953.0% |
| Cost of Revenue | $8.8M | +220.7% |
| Gross Profit | -$6.7M | -163.0% |
| R&D Expense | $110.4M | +89.4% |
| SG&A Expense | $42.0M | +18.9% |
| Operating Income | -$159.0M | -65.5% |
| Interest Expense | $0 | — |
| Income Tax | $0 | — |
| Net Income | -$153.4M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $119.5M | -53.8% |
| Short-term Investments | $193.7M | +63.1% |
| Accounts Receivable | $1.1M | +1522.9% |
| Inventory | $74K | -35.1% |
| Current Assets | $324.2M | -16.1% |
| Total Assets | $446.7M | -22.8% |
| Current Liabilities | $14.7M | -3.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$116.9M | -45.2% |
| Capital Expenditures | $2.9M | +21.2% |
| Investing Cash Flow | -$22.0M | +66.6% |
| Financing Cash Flow | -$78K | -100.5% |
| Free Cash Flow | -$119.8M | -44.5% |
| -59.7% |
| EPS (Basic) | -$0.87 | -55.4% |
| EPS (Diluted) | -$0.87 | -55.4% |
| Total Liabilities |
| $23.2M |
| -5.5% |
| Stockholders' Equity | $423.6M | -23.5% |